LWL
REGN icon

Leo Wealth LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Leo Wealth LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,646
Closed -$864K – 367
2025
Q2 		$864K Buy
1,646
+467
+40% +$261K 0.07% 181
2025
Q1 		$748K Buy
1,179
+544
+86% +$374K 0.11% 147
2024
Q4 		$452K Sell
635
-376
-37% -$316K 0.04% 246
2024
Q3 		$1.06M Buy
1,011
+108
+12% +$120K 0.1% 148
2024
Q2 		$949K Buy
+903
New +$875K 0.1% 152

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Leo Wealth LLC's REGN Position: Q3 2025 in Review

Leo Wealth LLC sold out of Regeneron Pharmaceuticals (REGN) in Q3 2025, closing a stake of 1,646 shares — an estimated $864K sold.

Leo Wealth LLC first reported a position in REGN in Q2 2024 and held it in 5 quarters. The position peaked at $1.06M in Q3 2024. 1,244 funds tracked by Wall St. Rank hold REGN as of Q3 2025.

  • Leo Wealth LLC reported no remaining Regeneron Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Leo Wealth LLC sold 1,646 Regeneron Pharmaceuticals shares in Q3 2025, an estimated $864K.
  • Leo Wealth LLC first reported a position in Regeneron Pharmaceuticals in Q2 2024 and held it in 5 quarters.
  • Leo Wealth LLC's Regeneron Pharmaceuticals position peaked at $1.06M in Q3 2024.
  • 1,244 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2025.

Based on Leo Wealth LLC's 13F filing for Q3 2025, filed 14 Nov 2025.